Cannabinoids and Cys-loop receptors; potential targets for medicinal marijuana – University of Copenhagen

Forward this page to a friend Resize Print kalender-ikon Bookmark and Share

DRA > Activities > 2017 > Symposia and lectures > Cannabinoids and Cys-l...

Cannabinoids and Cys-loop receptors; potential targets for medicinal marijuana

Lecture by Professor Mary Collins, Faculty of Pharmacy, The University of Sydney, Australia

Cannabinoids and in particular, cannabidiol, cannabichromene and cannabigerol are significant non-intoxicating components of medicinal marijuana. There has been much debate around their anti-epileptic, anxiolytic and anti-hyperalgesic properties. The mechanism of action of cannabinoids in producing such effects remains unclear. Despite evidence that some endogenous and synthetic cannabinoids interact with Cys-loop receptors, no-one has significantly investigated the effects of cannabinoids at these receptors. Mary Collins will discuss the action of cannabinoids at GABAA  and glycine receptors and compare their pharmacological properties  to their proclaimed physiological effects.

The lecture is organized on behalf of the graduate programme in pharmaceutical sciences, Drug Research Academy, by Bente Frølund, Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen.

Participation is free of charge and open for attendance by all interested parties. It is not necessary to pre-register.